EP4 may mediate the cardiac hypertrophy through EGFR/ERK1/2/Stat3 signaling, whereas PGE2-EP4 signaling may protect the heart from MI/R injury through cAMP/PKA or Stat3 pathway. The gene discussed is EGFR; the disease is cardiac hypertrophy.